We thus hypothesized that, in bone cancer state (especially in the early phase), CXCL12 is produced in DRG nociceptive neurons that innervate the tumor-bearing limb, and in turn axonally transported to the surface layers of SCDH where it may be released locally. Here, CXCL12 is linked to neoplasm.